AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 280: E489-E495, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimaraki, E. V.
Right arrow Articles by Barkan, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimaraki, E. V.
Right arrow Articles by Barkan, A. L.
Vol. 280, Issue 3, E489-E495, March 2001

Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiator

Eleni V. Dimaraki1, Craig A. Jaffe1, Roberta Demott-Friberg1, Mary Russell-Aulet1, Cyril Y. Bowers2, Peter Marbach3, and Ariel L. Barkan1

1 Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Michigan and Veterans Affairs Medical Center, Ann Arbor, Michigan 48109; 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Tulane University, New Orleans, Louisiana 70112; and 3 Novartis Pharma Ltd., CH-4002 Basel, Switzerland

To test whether endogenous hypothalamic somatostatin (SRIH) fluctuations are playing a role in the generation of growth hormone (GH) pulses, continuous subcutaneous octreotide infusion (16 µg/h) was used to create constant supraphysiological somatostatinergic tone. Six healthy postmenopausal women (age 67 ± 3 yr, body mass index 24.7 ± 1.2 kg/m2) were studied during normal saline and octreotide infusion providing stable plasma octreotide levels of 2,567 ± 37 pg/ml. Blood samples were obtained every 10 min for 24 h, and plasma GH was measured with a sensitive chemiluminometric assay. Octreotide infusion suppressed 24-h mean GH by 84 ± 3% (P = 0.00026), GH pulse amplitude by 90 ± 3% (P = 0.00031), and trough GH by 54 ± 5% (P = 0.0012), whereas GH pulse frequency remained unchanged. The response of GH to GH-releasing hormone (GHRH) was not suppressed, and the GH response to GH-releasing peptide-6 (GHRP-6) was unaffected. We conclude that, in women, periodic declines in hypothalamic SRIH secretion are not the driving force of endogenous GH pulses, which are most likely due to episodic release of GHRH and/or the endogenous GHRP-like ligand.

growth hormone-releasing peptide; humans; pituitary; hypothalamic control


This article has been cited by other articles:


Home page
J. Neurosci.Home page
N. Baccam, G. Alonso, T. Costecalde, P. Fontanaud, F. Molino, I. C. A. F. Robinson, P. Mollard, and P.-F. Mery
Dual-Level Afferent Control of Growth Hormone-Releasing Hormone (GHRH) Neurons in GHRH-Green Fluorescent Protein Transgenic Mice
J. Neurosci., February 14, 2007; 27(7): 1631 - 1641.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. R. Biermasz, A. M. Pereira, M. Frolich, J. A. Romijn, J. D. Veldhuis, and F. Roelfsema
Octreotide represses secretory-burst mass and nonpulsatile secretion but does not restore event frequency or orderly GH secretion in acromegaly
Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E25 - E30.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. V. Dimaraki, C. A. Jaffe, C. Y. Bowers, P. Marbach, and A. L. Barkan
Pulsatile and nocturnal growth hormone secretions in men do not require periodic declines of somatostatin
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E163 - E170.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. G. Maheshwari, S. S. Pezzoli, A. Rahim, S. M. Shalet, M. O. Thorner, and G. Baumann
Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance
Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E943 - E951.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online